Insider Buy: Precigen
4:08PM ET 1/31/2023 MT NewswiresRandal J Kirk, 10% Owner, Director, on January 27, 2023, executed a purchase for 11,428,571 shares in Precigen (PGEN) for $19,999,999. Following the Form 4...
Randal J Kirk, 10% Owner, Director, on January 27, 2023, executed a purchase for 11,428,571 shares in Precigen (PGEN) for $19,999,999. Following the Form 4...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Precigen (PGEN) said Friday it has closed its public offering of common stock, raising about $75 million in gross proceeds. The company said it has sold...
Health care stocks were ending little changed this afternoon, with the NYSE Health Care Index climbing 0.1% and the Health Care Select Sector SPDR Fund...
Address | 20358 Seneca Meadows Parkway Germantown, Maryland 20876 |
Phone | +1.301.556.9900 |
Number of Employees | 882 |
Recent SEC Filing | 01/31/2023![]() |
President, Chief Executive Officer & Director | Helen Sabzevari |
Chief Operating Officer | Rutul R. Shah |
Chief Financial Officer | Harry Thomasian |
Chief Science Officer | Thomas David Reed |
Price Open | $1.89 |
Previous Close | $1.87 |
52 Week Range | $1.12 - 2.90 |
Market Capitalization | $454.3 M |
Shares Outstanding | 251.0 M |
Sector | Health Technology |
Industry | Biotechnology | Next Earnings Announcement | 03/07/2023 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | 15.25 |
Earnings per Share | -$0.34 |
Beta vs. S&P 500 | N/A |
Revenue | $160.6 M |
Net Profit Margin | -102.78% |
Return on Equity | -82.23% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |